The percentage is higher in some cancers, and researchers need to understand why, for example, the treatment benefits patients with melanoma but not pancreatic cancer. (washingtonpost.com)
The researchers believe that in the future this discovery may benefit patients in two ways. (sciencedaily.com)
Their work could one day benefit patients who suffer from inflammatory bowel disease or organ transplant rejection. (gladstone.org)